EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Trends in the Detection of Erythropoietin Receptor Agonists (ERAs) in Anti‐Doping: An Analysis of Recent Adverse Analytical Findings (AAFs)

Tristan Equey iD, Julian Broséus, Norbert Baume iD, Reid Aikin iD

Drug Testing and Analysis · 2025

DOI: 10.1002/dta.3828 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Tristan Equey und 3 weiteren Autor:innen. Beteiligte Einrichtung: World Anti-Doping Agency (WADA), Montreal, Canada. Hauptthemen laut MEDLINE: Doping in Sports, Substance Abuse Detection, Receptors, Erythropoietin, Erythropoietin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti‐doping efforts aim to reduce the prevalence of doping through a combination of education, deterrence, and detection. Detection of doping practices, for example through testing and/or investigations, aims both to catch committed dopers and deter potential dopers. To date, little empirical evidence is available examining the ability of detection strategies to deter athletes from doping. Here, trends in adverse analytical findings (AAFs) for EPO or other EPO‐Receptor Agonists (ERAs) were examined over an 8‐year period in order to assess the impact of ERA testing and detection on athlete behavior. It was observed that the majority (62.8%) of ERA AAFs occur on samples collected on the day of a competition. Evidence is also presented that the largest fraction of ERA AAFs occurs on the first sample ever taken from an athlete (43.2%), and that the ERA AAF rates decline steadily as athletes continue to be tested. These findings provide evidence of a deterrent effect of testing on ERA use in sport.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Doping in SportsSubstance Abuse DetectionReceptors, ErythropoietinErythropoietinHumansAthletesPerformance-Enhancing Substances

Stichwörter der Autor:innen

anti‐dopingblood dopingerythropoietin (EPO)erythropoietin receptor agonists (ERAs)

Substanzen

Receptors, ErythropoietinErythropoietinPerformance-Enhancing Substances

Autor:innen und Institutionen

  • World Anti-Doping Agency (WADA), Montreal, Canada.

ORCID-Profile: Tristan Equey, Norbert Baume, Reid Aikin

Zitieren

APA

Equey, T., Broséus, J., Baume, N., & Aikin, R. (2025). Trends in the Detection of Erythropoietin Receptor Agonists (ERAs) in Anti‐Doping: An Analysis of Recent Adverse Analytical Findings (AAFs). Drug Testing and Analysis. https://doi.org/10.1002/dta.3828

Vancouver

Equey T, Broséus J, Baume N, Aikin R. Trends in the Detection of Erythropoietin Receptor Agonists (ERAs) in Anti‐Doping: An Analysis of Recent Adverse Analytical Findings (AAFs). Drug Testing and Analysis. 2025. doi:10.1002/dta.3828

BibTeX
@article{Equey2025,
  author = {Equey, Tristan and Broséus, Julian and Baume, Norbert and Aikin, Reid},
  title = {Trends in the Detection of Erythropoietin Receptor Agonists (ERAs) in Anti‐Doping: An Analysis of Recent Adverse Analytical Findings (AAFs)},
  journal = {Drug Testing and Analysis},
  year = {2025},
  doi = {10.1002/dta.3828}
}
Kostenlos starten →